{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:52:41Z","timestamp":1774075961543,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04280-5","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T05:05:11Z","timestamp":1731128711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association between the fluoxetine use and the occurrence of coronary heart disease: a nationwide retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Fang-Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tse","family":"Sheih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Tung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Kun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Ching","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien\u2010An","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"issue":"10258","key":"4280_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"3","key":"4280_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/2047487314520785","volume":"21","author":"EJ Brunner","year":"2014","unstructured":"Brunner EJ, Shipley MJ, Britton AR, Stansfeld SA, Heuschmann PU, Rudd AG, Wolfe CD, Singh-Manoux A, Kivimaki M. Depressive disorder, coronary heart disease, and stroke: dose\u2013response and reverse causation effects in the Whitehall II cohort study. Eur J Prev Cardiol. 2014;21(3):340\u20136.","journal-title":"Eur J Prev Cardiol"},{"key":"4280_CR3","doi-asserted-by":"crossref","unstructured":"Reid S, Barbui C. Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. BMJ 2010; 340.","DOI":"10.1136\/bmj.c1468"},{"issue":"8","key":"4280_CR4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/archgenpsychiatry.2009.81","volume":"66","author":"M Olfson","year":"2009","unstructured":"Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8):848\u201356.","journal-title":"Arch Gen Psychiatry"},{"key":"4280_CR5","doi-asserted-by":"crossref","unstructured":"Cipriani A, Brambilla P, Furukawa TA, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Reviews 2005;4.","DOI":"10.1002\/14651858.CD004185.pub2"},{"issue":"1","key":"4280_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9343(99)00301-0","volume":"108","author":"HW Cohen","year":"2000","unstructured":"Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108(1):2\u20138.","journal-title":"Am J Med"},{"issue":"7314","key":"4280_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/bmj.323.7314.666","volume":"323","author":"J Hippisley-Cox","year":"2001","unstructured":"Hippisley-Cox J, Pringle M, Hammersley V, Crown N, Wynn A, Meal A, Coupland C. Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ. 2001;323(7314):666\u20139.","journal-title":"BMJ"},{"issue":"1","key":"4280_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijcard.2009.06.036","volume":"145","author":"LB Rosenberg","year":"2010","unstructured":"Rosenberg LB, Whang W, Shimbo D, Shah A, Shapiro PA, Davidson KW. Exposure to tricyclic antidepressants is associated with an increased risk of incident CHD events in a population-based study. Int J Cardiol. 2010;145(1):124\u20135.","journal-title":"Int J Cardiol"},{"issue":"4","key":"4280_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/hrt.2004.037457","volume":"91","author":"L Tata","year":"2005","unstructured":"Tata L, West J, Smith C, Farrington P, Card T, Smeeth L, Hubbard R. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91(4):465\u201371.","journal-title":"Heart"},{"issue":"16","key":"4280_CR10","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1161\/hc4101.097519","volume":"104","author":"WH Sauer","year":"2001","unstructured":"Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104(16):1894\u20138.","journal-title":"Circulation"},{"issue":"4","key":"4280_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.amjmed.2010.11.015","volume":"124","author":"JF Scherrer","year":"2011","unstructured":"Scherrer JF, Garfield LD, Lustman PJ, Hauptman PJ, Chrusciel T, Zeringue A, Carney RM, Freedland KE, Bucholz KK, Owen R. Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med. 2011;124(4):318\u201324.","journal-title":"Am J Med"},{"issue":"12","key":"4280_CR12","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1161\/01.CIR.94.12.3123","volume":"94","author":"LA Pratt","year":"1996","unstructured":"Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation. 1996;94(12):3123\u20139.","journal-title":"Circulation"},{"issue":"1","key":"4280_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/01.CIR.0000079172.43229.CD","volume":"108","author":"WH Sauer","year":"2003","unstructured":"Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108(1):32\u20136.","journal-title":"Circulation"},{"issue":"11","key":"4280_CR14","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jacc.2008.10.060","volume":"53","author":"W Whang","year":"2009","unstructured":"Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the nurses\u2019 Health Study. J Am Coll Cardiol. 2009;53(11):950\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4280_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/eurheartj\/ehq438","volume":"32","author":"M Hamer","year":"2011","unstructured":"Hamer M, Batty GD, Seldenrijk A, Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J. 2011;32(4):437\u201342.","journal-title":"Eur Heart J"},{"issue":"3","key":"4280_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1365-2125.2011.04008.x","volume":"72","author":"SE Kimmel","year":"2011","unstructured":"Kimmel SE, Schelleman H, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD. The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol. 2011;72(3):514\u20137.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"4280_CR17","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.amjcard.2010.11.017","volume":"107","author":"C Pizzi","year":"2011","unstructured":"Pizzi C, Rutjes AWS, Costa GM, Fontana F, Mezzetti A, Manzoli L. Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol. 2011;107(7):972\u20139.","journal-title":"Am J Cardiol"},{"issue":"1","key":"4280_CR18","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/s41598-018-19886-x","volume":"8","author":"G Scabia","year":"2018","unstructured":"Scabia G, Barone I, Mainardi M, Ceccarini G, Scali M, Buzzigoli E, Dattilo A, Vitti P, Gastaldelli A, Santini F. The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF. Sci Rep. 2018;8(1):1781.","journal-title":"Sci Rep"},{"key":"4280_CR19","doi-asserted-by":"publisher","first-page":"117307","DOI":"10.1016\/j.lfs.2020.117307","volume":"245","author":"GRF Braz","year":"2020","unstructured":"Braz GRF, da Silva AI, Silva SCA, Pedroza AAS, de Lemos MDT, de Lima FAS, Silva TLA, Lagranha CJ. Chronic serotonin reuptake inhibition uncouples brown fat mitochondria and induces beiging\/browning process of white fat in overfed rats. Life Sci. 2020;245:117307.","journal-title":"Life Sci"},{"issue":"11","key":"4280_CR20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1161\/ATVBAHA.120.312470","volume":"40","author":"HW Kim","year":"2020","unstructured":"Kim HW, Shi H, Winkler MA, Lee R, Weintraub NL. Perivascular adipose tissue and vascular perturbation\/atherosclerosis. Arterioscler Thromb Vasc Biol. 2020;40(11):2569\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"4280_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/metabo11050319","volume":"11","author":"CL Roth","year":"2021","unstructured":"Roth CL, Molica F, Kwak BR. Browning of white adipose tissue as a therapeutic tool in the fight against atherosclerosis. Metabolites. 2021;11(5):319.","journal-title":"Metabolites"},{"key":"4280_CR22","doi-asserted-by":"crossref","unstructured":"Hsieh C-Y, Su C-C, Shao S-C, Sung S-F, Lin S-J, Kao Yang Y-H. Lai EC-C: Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol 2019:349\u201358.","DOI":"10.2147\/CLEP.S196293"},{"issue":"3","key":"4280_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng CL, Kao YHY, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236\u201342.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"18","key":"4280_CR24","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"C-Y Wu","year":"2012","unstructured":"Wu C-Y, Chen Y-J, Ho HJ, Hsu Y-C, Kuo KN, Wu M-S, Lin J-T. Association between nucleoside analogues and risk of hepatitis B virus\u2013related hepatocellular carcinoma recurrence following liver resection. JAMA. 2012;308(18):1906\u201313.","journal-title":"JAMA"},{"issue":"1","key":"4280_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/pds.1324","volume":"16","author":"CS Gau","year":"2007","unstructured":"Gau CS, Chang IS, Lin Wu FL, Yu HT, Huang YW, Chi CL, Chien SY, Lin KM, Liu MY, Wang HP. Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co\u2010medication in Taiwan. Pharmacoepidemiol Drug Saf. 2007;16(1):86\u201395.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"17","key":"4280_CR26","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2016.16435","volume":"316","author":"DN Kyriacou","year":"2016","unstructured":"Kyriacou DN, Lewis RJ. Confounding by indication in clinical research. JAMA. 2016;316(17):1818\u20139.","journal-title":"JAMA"},{"issue":"2","key":"4280_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/biomet\/74.2.289","volume":"74","author":"R Gill","year":"1987","unstructured":"Gill R, Schumacher M. A simple test of the proportional hazards assumption. Biometrika. 1987;74(2):289\u2013300.","journal-title":"Biometrika"},{"issue":"2","key":"4280_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cpr.2007.05.005","volume":"28","author":"K Goldston","year":"2008","unstructured":"Goldston K, Baillie AJ. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev. 2008;28(2):288\u2013306.","journal-title":"Clin Psychol Rev"},{"key":"4280_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnins.2013.00036","volume":"7","author":"MH Donovan","year":"2013","unstructured":"Donovan MH, Tecott LH. Serotonin and the regulation of mammalian energy balance. Front NeuroSci. 2013;7:36.","journal-title":"Front NeuroSci"},{"key":"4280_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00004850-199501004-00006","volume":"9","author":"D Baldwin","year":"1995","unstructured":"Baldwin D, Rudge S. The role of serotonin in depression and anxiety. Int Clin Psychopharmacol. 1995;9:41\u20135.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"4280_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-016-1163-4","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-M\u00f8ller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017;17(1):1\u201328.","journal-title":"BMC Psychiatry"},{"key":"4280_CR32","doi-asserted-by":"publisher","first-page":"111848","DOI":"10.1016\/j.biopha.2021.111848","volume":"141","author":"Y-J Chiu","year":"2021","unstructured":"Chiu Y-J, Tu H-H, Kung M-L, Wu H-J, Chen Y-W. Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis. Biomed Pharmacother. 2021;141:111848.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4280_CR33","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/ncomms7356","volume":"6","author":"JF Berb\u00e9e","year":"2015","unstructured":"Berb\u00e9e JF, Boon MR, Khedoe PPS, Bartelt A, Schlein C, Worthmann A, Kooijman S, Hoeke G, Mol IM, John C. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun. 2015;6(1):6356.","journal-title":"Nat Commun"},{"issue":"4","key":"4280_CR34","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cvr\/cvac131","volume":"119","author":"Z Ying","year":"2023","unstructured":"Ying Z, Tramper N, Zhou E, Boon MR, Rensen PC, Kooijman S. Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans. Cardiovascular Res. 2023;119(4):905\u201318.","journal-title":"Cardiovascular Res"},{"key":"4280_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10863-015-9617-9","volume":"47","author":"A Da Silva","year":"2015","unstructured":"Da Silva A, Braz G, Pedroza A, Nascimento L, Freitas C, Ferreira D, Manh\u00e3es de Castro R, Lagranha C. Fluoxetine induces lean phenotype in rat by increasing the brown\/white adipose tissue ratio and UCP1 expression. J Bioenerg Biomembr. 2015;47:309\u201318.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"4280_CR36","first-page":"289645","volume":"2010","author":"R Monteiro","year":"2010","unstructured":"Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediat Inflamm. 2010;2010(1):289645.","journal-title":"Mediat Inflamm"},{"issue":"3","key":"4280_CR37","doi-asserted-by":"publisher","first-page":"e00231","DOI":"10.1002\/prp2.231","volume":"4","author":"V Caiaffo","year":"2016","unstructured":"Caiaffo V, Oliveira BD, de S\u00e1 FB, Ev\u00eancio Neto J. Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine. Pharmacol Res Perspect. 2016;4(3):e00231.","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"4280_CR38","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/ajcn\/61.5.1020","volume":"61","author":"R Bross","year":"1995","unstructured":"Bross R, Hoffer LJ. Fluoxetine increases resting energy expenditure and basal body temperature in humans. Am J Clin Nutr. 1995;61(5):1020\u20135.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"4280_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.adaj.2015.02.010","volume":"146","author":"J Hyman","year":"2015","unstructured":"Hyman J. The limitations of using insurance data for research. J Am Dent Association. 2015;146(5):283\u20135.","journal-title":"J Am Dent Association"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04280-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04280-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04280-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T06:02:21Z","timestamp":1731132141000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04280-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4280"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04280-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"18 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) of Fu-Jen Catholic University approved the study and waived the need for informed consent because the identifcation of subjects in the National Health Insurance Research Database (NHIRD) had been de-identifed prior to their release for research in order to ensure confdentiality (FJU-IRB No: C104014). We conducted this study in accordance with the Code of Ethics of the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"F-L Li, Y-T Shieh, M-H Lin, Y-C Chen, W-T Wu, T-K Lin, Y\u2010C Chou and C\u2010A Sun have disclosed that they have no relationships with or financial interests in any commercial companies related to this study or article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of financial\/other relationships"}}],"article-number":"628"}}